[4] University of Chicago Medicine,Comprehensive Hypertension Center, Department of Medicine
来源:
Nature Reviews Nephrology
|
2018年
/
14卷
关键词:
D O I:
暂无
中图分类号:
学科分类号:
摘要:
Many considered the failure of the SYMPLICITY HTN-3 trial to represent the end of therapeutic renal denervation. However, promising preliminary data from the SPYRAL HTN-OFF MED study and more recently the SPYRAL HTN-ON MED and RADIANCE-HTN SOLO studies support the efficacy of this intervention for blood pressure lowering in patients with hypertension.